Google’s Life Sciences division is working with DexCom, a leading continuous glucose-monitoring (CGM) company, to develop smaller, better devices for people with diabetes.

Through the partnership, Google and DexCom will develop cheaper, miniaturised glucose monitors, combining Google’s electronics platform with DexCom’s sensor technology to improve care for patients.

“This partnership has the potential to change the face of diabetes technology forever,” said DexCom’s President and CEO, Kevin Sayer.

“Working together, we believe we can introduce products that will move us beyond our core Type 1 business to become the standard of care for all people living with diabetes,” continued Sayer.

Diabetes patients will be able to use the disposable bandage-sized sensor, which is connected to the cloud, to continuously check their blood sugar levels. DexCom hopes the device will eventually replace painful finger prick test.

DexCom says the collaboration will allow the CGM devices to better utilize the data they gather in a way that should improve patient outcomes and reduce their costs. The goal is to empower more people to control their diabetes with real-time and actionable information.

The partnership with DexCom is the second diabetes project the Life Sciences division is working on. Last year Google joined forces with pharmaceutical company, Novartis, to develop a contact lens that can monitor a person’s blood sugar levels continuously.

“We’re committed to developing new technologies that will help move health care from reactive to proactive,” said Google’s Head of Life Sciences, Andrew Conrad. “This collaboration is another step towards expanding monitoring options and making it easier for people with diabetes to proactively manage their health.”

For more information contact news@eHealthNews.co.za, like us on Facebook or tweet us @eHealthNewsZA.